Geriatric and Oncologic Assessment Before Treatment (GOAT)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02671994|
Recruitment Status : Unknown
Verified January 2019 by Sambavy Nadaraja, Odense University Hospital.
Recruitment status was: Active, not recruiting
First Posted : February 2, 2016
Last Update Posted : January 4, 2019
|Condition or disease||Intervention/treatment||Phase|
|Cancer||Other: G8 screening Other: Geriatric assessment||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||114 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Significance of Geriatric Assessment for Optimal Treatment of Older Cancer Patients|
|Study Start Date :||January 2016|
|Estimated Primary Completion Date :||December 2019|
|Estimated Study Completion Date :||December 2019|
Experimental: A (experimental group)
Oncologic treatment decision based on G8 screening followed by geriatric assessment and subsequent MDT, if needed, in addition to standard assessment (ECOG Performance Status + clinical assessment).
Other: G8 screening
Other: Geriatric assessment
No Intervention: B (control group)
Oncologic treatment decision based on standard assessment (ECOG Performance Status + clinical assessment).
- Feasibility of planned oncologic treatment (number of participants, who complete the planned oncologic treatment) [ Time Frame: 2 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02671994
|Odense University Hospital|
|Odense, Denmark, 5000|
|Study Director:||Jørn Herrstedt, MD, DMSc||Odense University Hospital|